You are here

  • Home
  • Archive
  • Volume 68, Issue 12
  • Targeted delivery of liposomal dexamethasone phosphate to the spleen provides a persistent therapeutic effect in rat antigen-induced arthritis

Article Text

Article menu
Download PDFPDF
Letter
Targeted delivery of liposomal dexamethasone phosphate to the spleen provides a persistent therapeutic effect in rat antigen-induced arthritis

https://doi.org/10.1136/ard.2009.108985

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests SP is founder and shareholder of Novosom AG.

    • UR and RWK contributed equally.

    • Provenance and Peer review Not commissioned; externally peer reviewed.